We are live on
!
Find out more
FI
FCM Investments Portfolio holdings
AUM
$70.1M
1-Year Est. Return
98.98%
This Fund
S&P 500
This Quarter
Est. Return
+4.83%
1 Year Est. Return
+98.98%
3 Year Est. Return
+210.12%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$131M
AUM Growth
-$27.7M
(-17%)
Cap. Flow
-$33.2M
Cap. Flow
% of AUM
-25.35%
Top 10 Holdings %
Top 10 Hldgs %
69.97%
Holding
86
New
–
Increased
–
Reduced
26
Closed
38
Top Buys
No buys this quarter
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$3.63M |
| 2 |
Intuitive Surgical
ISRG
|
+$3.08M |
| 3 |
Cisco
CSCO
|
+$2.98M |
| 4 |
Verisk Analytics
VRSK
|
+$2.47M |
| 5 |
CELG
Celgene Corp
CELG
|
+$2.32M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.22% |
| 2 | Communication Services | 21.94% |
| 3 | Healthcare | 20.28% |
| 4 | Industrials | 3.39% |
| 5 | Energy | 3.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Rayonier
RYN
$6.31B
| $797K | 0.61% |
30,521
-7,054
| -19% | -$182K |
|
27
Verizon
VZ
$205B
| $741K | 0.57% |
16,603
-4,250
| -20% | -$198K |
|
|
APU
28
DELISTED
AmeriGas Partners, L.P.
APU
| $737K | 0.56% |
16,314
-3,450
| -17% | -$155K |
|
29
AT&T
T
$173B
| $711K | 0.54% |
24,967
-5,428
| -18% | -$160K |
|
30
Pfizer
PFE
$160B
| $700K | 0.53% |
21,955
-4,954
| -18% | -$156K |
|
31
Enterprise Products Partners
EPD
$82.1B
| $689K | 0.53% |
25,450
-5,700
| -18% | -$154K |
|
|
MMP
32
DELISTED
Magellan Midstream Partners, L.P.
MMP
| $609K | 0.47% |
8,540
-2,100
| -20% | -$154K |
|
33
Seagate
STX
$193B
| $599K | 0.46% |
15,460
-3,600
| -19% | -$157K |
|
|
RDS.B
34
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
| $591K | 0.45% |
10,855
-2,450
| -18% | -$136K |
|
35
Microsoft
MSFT
$3.59T
| $538K | 0.41% |
7,800
| – | – |
|
|
MXIM
36
DELISTED
Maxim Integrated Products
MXIM
| $478K | 0.37% |
10,650
-21,104
| -66% | -$969K |
|
37
GSK
GSK
$105B
| $446K | 0.34% |
8,280
-15,374
| -65% | -$820K |
|
38
Kimberly-Clark
KMB
$36.4B
| $352K | 0.27% |
2,730
-4,650
| -63% | -$605K |
|
39
Meta Platforms (Facebook)
META
$1.4T
| $325K | 0.25% |
2,150
| – | – |
|
40
Johnson & Johnson
JNJ
$651B
| $324K | 0.25% |
2,450
| – | – |
|
41
Booking.com
BKNG
$158B
| $309K | 0.24% |
4,125
| – | – |
|
42
Union Pacific
UNP
$183B
| $301K | 0.23% |
2,766
| – | – |
|
43
Cummins
CMI
$80.9B
| $260K | 0.2% |
1,600
| – | – |
|
44
Plains All American Pipeline
PAA
$17.4B
| $248K | 0.19% |
9,450
-25,884
| -73% | -$717K |
|
|
RTN
45
DELISTED
Raytheon Company
RTN
| $242K | 0.18% |
1,500
| – | – |
|
46
Mastercard
MA
$509B
| $231K | 0.18% |
1,900
| – | – |
|
47
3M
MMM
$92.3B
| $229K | 0.18% |
1,316
| – | – |
|
48
UnitedHealth
UNH
$350B
| $204K | 0.16% |
1,100
| – | – |
|
49
AbbVie
ABBV
$468B
| – | – |
-7,500
| Closed | -$489K |
|
50
Abbott
ABT
$202B
| – | – |
-6,600
| Closed | -$293K |
|
Similar funds
YCM
MIM
HC
KCM
PSW
IT
AZA
SIA
FCM Investments's Q2 2017 Portfolio in Review
As of Q2 2017, FCM Investments held 86 positions worth $131M, down 17% from $159M the previous quarter. Its ten largest holdings account for 70% of the portfolio.
FCM Investments withdrew a net $33.2M in Q2 2017, closing 38 positions and reducing 26 holdings. Its most notable exit was Gilead Sciences, an estimated $3.63M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 23% a quarter earlier, followed by Communication Services and Healthcare.
- FCM Investments's biggest Q2 2017 reduction was Intuitive Surgical, cutting an estimated $3.08M.
- FCM Investments fully exited Gilead Sciences in Q2 2017, selling an estimated $3.63M.
- FCM Investments's ten largest holdings make up 70% of its $131M portfolio in Q2 2017.
- FCM Investments opened 0 new positions and closed 38 in Q2 2017.
- FCM Investments's portfolio value fell 17% quarter-over-quarter to $131M.
Based on FCM Investments's 13F filing for Q2 2017, filed 28 Jul 2017.